| Literature DB >> 30734593 |
Murad Mutlu1, M Hakan Korkmaz2, Ender Simsek3, Emine Terzi3, Beyza Ecem Oz Bedir3, Tugba Kevser Uysal3, Omer Bayir1, Guleser Saylam4, Ozen Ozensoy Guler3.
Abstract
Head and neck cancer (HNC) is one of the most common malignancies in the world. HNC is a group of cancers that starts in the mouth, nose, throat, larynx, sinuses, or salivary glands. According to this section of the body parts; induction of cancer can be associated with CO2 and oxidative stress. The aim of this study is to assess the activities of carbonic anhydrase (CA), catalase (CAT), paraoxonase1 (PON1), and xanthine oxidase (XO) activities in 89 HNC patients and 115 healthy volunteers. Paraoxonase1 activity was found lower in HNC cancer patients. There is no statistically significant difference between patients and controls for catalase, carbonic anhydrase, and xanthine oxidase enzyme levels. According to this results, paraoxonase1 levels could be a candidate as an oxidative marker in HNC patients, but further studies are needed to investigate the other type of cancer related PON1 and the other enzyme levels.Entities:
Keywords: Carbonic anhydrase; catalase; head and neck cancer; paraoxonase; xanthine oxidase
Mesh:
Substances:
Year: 2019 PMID: 30734593 PMCID: PMC6327982 DOI: 10.1080/14756366.2018.1555157
Source DB: PubMed Journal: J Enzyme Inhib Med Chem ISSN: 1475-6366 Impact factor: 5.051
Demographic findings of the HNC patients.
| Patient ( | Control ( | Total ( | |
|---|---|---|---|
| 59.3 ± 9.2 | 57.6 ± 11.3 | 58.3 ± 10.4 | |
| Male | 77 (86.5) | 94 (81.7) | 171 (83.8) |
| Female | 12 (13.5) | 21 (18.3) | 33 (16.2) |
| T1 | 15 (16.9) | – | – |
| T2 | 24 (27.0) | – | – |
| T3 | 31 (34.8) | – | – |
| T4 | 19 (21.3) | – | – |
| Larynx | 74 (83.1) | – | – |
| Oral cavity | 15 (16.9) | – | – |
Comparison of enzyme levels.
| Patient Median (min-max) | Control Median (min-max) | p | |
|---|---|---|---|
| CA | 2.29 (0.70 – 3.45) | 2.24 (1.26 – 4.11) | .969 |
| CAT | 16.87 (0.70 – 39.37) | 18.98 (0.70 – 97.03) | .194 |
| PON | 65.70 (0.61 – 271.40) | 103.16 (4.30 – 459.30) | |
| XO | 50.11 (0.00 – 1634.32) | 67.90 (0.00 – 248.95) | .080 |
1n = 76 for patients; n = 115 for controls.
2n = 64 for patients; n = 115 for controls.
3n = 88 for patients; n = 115 for controls.
4n = 88 for patients; n = 115 for controls.
Figure 4.Paraoxonase (PON1) enzyme activity levels on HNC cases and control group.